Cerebral ptosis: An ominous sign in stroke—A retrospective study
Abstract Introduction Cerebral ptosis is defined as the drooping of eyelids due to lesions in the cerebral hemispheres. Cerebral ptosis is due to either unilateral or bilateral hemispheric damage without brainstem involvement. Ischemic strokes are the most common etiology leading to hemispheric damage. Aims To assess the prevalence of cerebral ptosis in ischemic strokes and to correlate the presence of cerebral ptosis with the outcome of the patients. To also assess the demographic profile of these patients. Materials and Methods This is a retrospective study from June 2022 to August 2024. All patients diagnosed as acute stroke presenting with cerebral ptosis within day 3 of stroke were included. Patients with a reduced level of consciousness, brainstem involvement, and those with signs of impending herniation were excluded. The modified Rankin scale (mRS) on the day of admission and the day of discharge were compared. Results There were 26 patients with cerebral ptosis among 649 patients admitted with anterior circulation stroke (prevalence 4.01%). 84.6% ( n = 12) had right hemisphere involvement and 15.4% ( n = 4) had left side involvement. 88.5% ( n − = 23) had middle cerebral artery territory involvement and 7.7% ( n = 2) had internal carotid artery territory involvement. The mean mRS on admission was 4.42 and 4.81 on discharge (paired t ‐test 0.015). mRS 6 (death) was observed in four patients. Conclusion Cerebral ptosis is a supranuclear disorder with the most common etiology being vascular insult to the cerebral hemisphere. It is an ominous and rare clinical sign. Identification of this entity is important, and it is not to be confused with a reduced level of consciousness.
Authors
- Aswathy Sasidharan (ORCID: https://orcid.org/0000-0002-2825-3603)
- P. A. Fazal Ghafoor
- S. Arun Pranaav (ORCID: https://orcid.org/0009-0009-5730-6215)
Publication Details
- Journal
- Neurology and Clinical Neuroscience
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1111/ncn3.12864
- Primary Topic
- Neurological and metabolic disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00